Miracle Mile Advisors LLC Lowers Stock Position in Agilent Technologies, Inc. $A

Miracle Mile Advisors LLC trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 53.6% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 4,257 shares of the medical research company’s stock after selling 4,925 shares during the period. Miracle Mile Advisors LLC’s holdings in Agilent Technologies were worth $546,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. raised its position in Agilent Technologies by 1.8% in the second quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock worth $4,012,086,000 after acquiring an additional 589,219 shares in the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of Agilent Technologies by 10.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after purchasing an additional 1,273,994 shares during the period. Geode Capital Management LLC increased its holdings in shares of Agilent Technologies by 1.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock valued at $860,137,000 after purchasing an additional 115,183 shares in the last quarter. Generation Investment Management LLP lifted its stake in shares of Agilent Technologies by 15.9% in the second quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock valued at $681,609,000 after purchasing an additional 792,304 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Agilent Technologies by 18.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock valued at $448,748,000 after purchasing an additional 604,124 shares during the period.

Insider Transactions at Agilent Technologies

In other news, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the sale, the vice president directly owned 31,846 shares in the company, valued at $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Padraig Mcdonnell sold 911 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the transaction, the chief executive officer directly owned 32,058 shares in the company, valued at $4,591,987.92. The trade was a 2.76% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $137.82 on Monday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. The business’s fifty day moving average price is $144.41 and its two-hundred day moving average price is $131.60. The stock has a market cap of $39.07 billion, a PE ratio of 30.16, a price-to-earnings-growth ratio of 4.00 and a beta of 1.29. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The business’s revenue was up 9.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be paid a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, January 6th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio is 21.66%.

Wall Street Analyst Weigh In

A has been the subject of a number of research analyst reports. JPMorgan Chase & Co. increased their target price on shares of Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Wells Fargo & Company raised their price objective on Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Bank of America boosted their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 25th. Rothschild & Co Redburn initiated coverage on Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. Finally, Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $161.77.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.